Ian Gosling, Ph.D
Dr. Gosling founded ChemSim in 2002 to provide simulation expertise to the biopharma and biotechnology industries. Process simulation is the in-silico representation of the physical bioprocess and simulation can be used from initial conceptual design to full implementation of digital twins for process optimization.
​
Dr. Gosling was previously employed as a bioprocess simulation developer at Aspen Technology before becoming Director of Software at BioSepra. He was also a Senior Bioprocess Engineer at AEA Technology, Harwell, England and has guest lectured at Tufts University Department of Chemical Engineering, Boston, MA.
Dr. Gosling received his Ph.D. in Biochemical Engineering from Swansea University, Wales, UK.
ChemSim also utilizes independent consultants on a project basis to work with its core team of experts. This provides flexibility in offering the most comprehensive suite of services covering a broad range of expertise.
ARTICLES & PRESENTATIONS
-
"Bioprocess Simulation: Taking the Error out of Trial-and-Error," ​Innovations in Pharmaceutical Technology, Winter 2010.
-
"Bioprocess Simulations Gain Traction," Genetic Engineering News, Volume 26, Number 16, September 15, 2006
-
"Process simulation and modeling for industrial bioprocessing: tools and techniques," Industrial Biotechnology, 2005
-
"Optimizing productivity in multiproduct batch facilities," Genetic Engineering News, Sept 2003.
-
"Operating a multiproduct facility: the critical role of process simulation" BioTalk, Boston, May 2019